Home / Mesalazine / Austria
AT ATC A07EC02 · updated 2 Nov 2026
Mesalazine shortage in Austria
Is there a Mesalazine shortage in Austria?
Yes. As of 2 Nov 2026, 2 Mesalazine products are reported short in Austria, the first since 30 Jan 2026. The company estimate for the return is 31 Mar 2027. Main reason: increased demand.
Also short in Canada, Germany, France, Ireland, Czechia, Norway, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Salofalk 500 mg Zäpfchen, 10 Stück | Dr. Falk Pharma GmbH | 30 Jan 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Salofalk 500 mg Zäpfchen, 20 Stück limited | Dr. Falk Pharma GmbH | 21 May 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).